Back to results
RecruitingPhase 2

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

NCT06518837

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Trinitas Comprehensive Cancer Center

Elizabeth, New Jersey, United States

+6 additional locations

Contact

Coral Omene, MD., PhD

732-235-3374co273@cinj.rutgers.edu
View on ClinicalTrials.gov
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer — TrialFind